NMTC - NeuroOne Medical Technologies GAAP EPS of -$0.20
2023-08-14 16:59:50 ET
- NeuroOne Medical Technologies press release ( NASDAQ: NMTC ): Q3 GAAP EPS of -$0.20.
- Product revenue was $630,000 in the fiscal third quarter 2023, compared to product revenue of $32,000 in the fiscal third quarter 2022.
For further details see:
NeuroOne Medical Technologies GAAP EPS of -$0.20